• KASL clinical practice guidelines for management of chronic hepatitis B

• The Korean Association for the Study of the Liver

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 276 ~ 331

• Acute on chronic liver failure in cirrhosis

• Tonon Marta

• Piano Salvatore

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 273 ~ 275

• Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabo...

• Takamura Saori

• Teraki Yuichi, Katayama Eri, Kawaguchi Takumi, Kawaguchi Machiko, Nakano Dan, Tsutsumi Tsubasa,...

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 269 ~ 272

• Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients...

• An Ji-Hyun

• Shim Ju-Hyun

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 267 ~ 268

• Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with l...

• Huang Yi-Chun

• Chen Chih-Wei, Wei James Chun-Chung

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 265 ~ 266

• Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A ...

• Jeong Joon-Ho

• Shin Jung-Woo, Jung Seok-Won, Park Eun-Ji, Park Neung-Hwa

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 254 ~ 264

• Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide po...

• Kim Bo-Hyun

• Lee Dah-Hay, Jung Kyu-Won, Won Young-Joo, Cho Hyun-Soon

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 242 ~ 253

• Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in c...

• Yoon Ki-Tae

• Liu Hongqun, Zhang Jing, Han So-Jung, Lee Samuel S.

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 232 ~ 241

• Association between serum tumor necrosis factor-¥á and sarcopenia in liver cirrhosis

• Han Ji-Won

• Kim Da-In, Nam Hee-Chul, Chang U-Im, Yang Jin-Mo, Song Do-Seon

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 219 ~ 231

• Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (¡Â3 cm) he...

• Lee Jung-Nam

• Jin Young-Joo, Shin Seung-Kak, Kwon Jung-Hyun, Kim Sang-Gyune, Suh Young-Ju, Jeong Yu-Jin, ...

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 207 ~ 218

• Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military p...

• Lee Jae-Jun

• Kim Tae-Yun, Yang Hyun, Bae Si-Hyun

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 196 ~ 206

• Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcohol...

• Liu Wen-Yue

• Zhang Xiaofang, Li Gang, Tang Liang-Jie, Zhu Pei-Wu, Rios Rafael S., Zheng Kenneth I., Ma ...

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 183 ~ 195

• Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

• Lin Hung-Yao

• Tseng Tai-Chung

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 181 ~ 182

• Leaky gut-derived tumor necrosis factor-¥á causes sarcopenia in patients with liver cirrhosis

• Kawaguchi Takumi

• Torimura Takuji

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 177 ~ 180

• Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open

• Kim Bo-Hyun

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 174 ~ 176

• Cost-effectiveness of chronic hepatitis C screening and treatment

• Lee Hye-Won

• Lee Han-Kil, Kim Beom-Kyung, Chang Young, Jang Jae-Young, Kim Do-Young

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 164 ~ 173

• MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

• Kawaguchi Takumi

• Tsutsumi Tsubasa, Nakano Dan, Eslam Mohammed, George Jacob, Torimura Takuji

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 150 ~ 163

• Approaches to quantifying hepatitis B virus covalently closed circular DNA

• Zhang Henrik

• Tu Thomas

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 135 ~ 149

• The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Adva...

• Lee Hae-Lim

• Lee Sung-Won

• Clinical and Molecular Hepatology   2022  Volume.28  No.2 121 ~ 134